11.12.24 -- How Cidara Got Its Molecule Back

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.

Explore challenges in today’s changing market and solutions to help successfully develop and manufacture lifesaving products.

This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

Accurately quantifying viral titers is a challenge in the manufacturing of viral vectors. Gain valuable insights into improving the robustness and reproducibility of viral vector functional titers.

Explore the 3 phases of sterile injectable project tech transfer, including how to bridge information gaps and facilitate successful regulatory filing at this fundamental stage of drug development.

Partner with Mabion for comprehensive, state-of-the-art analytical services that ensure quality, safety, and regulatory compliance throughout every stage of your biologic drug’s lifecycle.

Explore the common pitfalls encountered in CGT CDMO collaborations, including communication breakdowns, differing regulatory interpretations, and program prioritization challenges.

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.

Navigate the path from concept to clinical reality by partnering with a CDMO that can provide the regulatory, clinical, and CMC expertise needed to move your therapeutic forward.

Learn about an off-gas analysis system for bioreactors that can provide slightly faster response times than commercially available analyzers.

Depending on the protein or peptide of interest for your therapeutic and your manufacturing goals, there are a number of different manufacturing approaches, each of which can be advantageous.

Argonaut Manufacturing Services is doubling down on growth, expanding its capabilities in combination product and drug-fill/finish manufacturing to meet the evolving needs of the biotech industry.

View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.